Financials Ryman Healthcare Limited Deutsche Boerse AG

Equities

Market Closed - Deutsche Boerse AG Other stock markets 10:17:21 2024-06-14 am EDT			5-day change	1st Jan Change
2.118 ^EUR	+0.86%		+0.86%	-35.84%

May. 27	Transcript : Ryman Healthcare Limited, 2024 Earnings Call, May 27, 2024
May. 26	Ryman Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	5,127	7,609	4,665	3,598	3,117	2,576	-	-
Enterprise Value (EV) ¹	6,873	9,876	7,227	5,901	3,117	5,096	4,935	4,835
P/E ratio	19.5 x	18.1 x	6.77 x	10.5 x	650 x	6.19 x	7.14 x	6.69 x
Yield	2.35%	1.46%	2.39%	1.68%	-	-	0.47%	2.07%
Capitalization / Revenue	12.1 x	16.7 x	9.17 x	6.3 x	4.52 x	3.49 x	3.19 x	2.95 x
EV / Revenue	16.2 x	21.7 x	14.2 x	10.3 x	4.52 x	6.9 x	6.1 x	5.53 x
EV / EBITDA	23.7 x	35.8 x	22.5 x	14.9 x	11.3 x	14.8 x	12.4 x	10.9 x
EV / FCF	-26.3 x	-22.9 x	-36.7 x	-	-	-20.3 x	14.9 x	43.2 x
FCF Yield	-3.81%	-4.36%	-2.73%	-	-	-4.93%	6.71%	2.32%
Price to Book	2.24 x	2.7 x	1.37 x	0.58 x	-	0.53 x	0.49 x	0.45 x
Nbr of stocks (in thousands)	497,736	497,289	497,345	685,308	685,147	685,147	-	-
Reference price ²	10.30	15.30	9.380	5.250	4.550	3.760	3.760	3.760
Announcement Date	6/12/20	5/20/21	5/19/22	5/19/23	5/26/24	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	423.9	455.8	508.8	571	689.9	739	808.4	874.1
EBITDA ¹	290	276.1	321.3	395.5	274.7	343.7	399.5	443.1
EBIT ¹	261.3	243.8	285.6	348.9	230.9	352.8	330.1	353.7
Operating Margin	61.65%	53.48%	56.14%	61.11%	33.47%	47.74%	40.83%	40.46%
Earnings before Tax (EBT) ¹	171.1	410.5	722.1	-	-144.9	584	412	408
Net income ¹	264.7	423.1	692.9	257.8	4.775	395.9	382.5	413.8
Net margin	62.45%	92.82%	136.18%	45.16%	0.69%	53.57%	47.31%	47.34%
EPS ²	0.5290	0.8460	1.386	0.4990	0.007000	0.6073	0.5269	0.5622
Free Cash Flow ¹	-261.6	-430.4	-197.1	-	-	-251	331	112
FCF margin	-61.72%	-94.44%	-38.73%	-	-	-33.96%	40.94%	12.81%
FCF Conversion (EBITDA)	-	-	-	-	-	-	82.85%	25.27%
FCF Conversion (Net income)	-	-	-	-	-	-	86.53%	27.06%
Dividend per Share ²	0.2420	0.2240	0.2240	0.0880	-	-	0.0178	0.0778
Announcement Date	6/12/20	5/20/21	5/19/22	5/19/23	5/26/24	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	1,746	2,268	2,562	2,303	-	2,520	2,359	2,259
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	6.022 x	8.213 x	7.973 x	5.823 x	-	7.331 x	5.904 x	5.098 x
Free Cash Flow ¹	-262	-430	-197	-	-	-251	331	112
ROE (net income / shareholders' equity)	10.8%	8.75%	8.14%	7.46%	-	7.16%	6.44%	6.31%
ROA (Net income/ Total Assets)	3.38%	5.02%	6.88%	2.2%	-	4.1%	2.8%	2.8%
Assets ¹	7,836	8,424	10,069	11,738	-	9,656	13,661	14,779
Book Value Per Share ²	4.600	5.660	6.870	9.030	-	7.080	7.690	8.310
Cash Flow per Share ²	0.9000	0.8300	1.170	1.260	-	1.000	1.100	1.040
Capex ¹	711	844	783	1,041	-	705	533	553
Capex / Sales	167.83%	185.08%	153.9%	182.33%	-	95.34%	65.89%	63.3%
Announcement Date	6/12/20	5/20/21	5/19/22	5/19/23	5/26/24	-	-	-

¹NZD in Million²NZD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.76 NZD

Average target price

6.048 NZD

Spread / Average Target

+60.85%

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+24.67%	88.39B
CVS HEALTH CORPORATION	-23.73%	75.6B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.24%	26.87B
FRESENIUS SE & CO. KGAA	+5.31%	17.81B
LABCORP HOLDINGS INC.	-12.06%	16.85B
QUEST DIAGNOSTICS INCORPORATED	-0.02%	15.31B
NATERA, INC.	+75.93%	13.53B
TENET HEALTHCARE CORPORATION	+82.63%	13.48B
PURE HEALTH HOLDING	-24.56%	13.01B